Characterization of immunity induced by M2e of influenza virus

Vaccine

Volumn 25, Issue 52, 2007, Pages 8868-8873

  Wu, Fan ^a   Huang, Jing He ^a   Yuan, Xiao Yi ^a   Huang, Wei Shan ^a   Chen, Ying Hua ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Immunity; Influenza A virus; M2e; Protection; Vaccine

Indexed keywords

ADJUVANT; CARRIER PROTEIN; FREUND ADJUVANT; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA MATRIX 2 PROTEIN; INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VIRUS; INFLUENZA VIRUS A; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTIBODIES, VIRAL; BODY WEIGHT; FEMALE; FREUND'S ADJUVANT; IMMUNOGLOBULIN G; INFLUENZA A VIRUS; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; T-LYMPHOCYTES; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL MATRIX PROTEINS;

EID: 36749090029     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.056     Document Type: Article

References (16)

1. Gerhard W., Mozdzanowska K., and Zharikova D. Prospects for universal influenza virus vaccine. Emerg Infect Dis 12 4 (2006) 569-574
2. Zebedee S.L., and Lamb R.A. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 62 8 (1988) 2762-2772
3. Treanor J.J., Tierney E.L., Zebedee S.L., Lamb R.A., and Murphy B.R. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 64 3 (1990) 1375-1377
4. Slepushkin V.A., Katz J.M., Black R.A., Gamble W.C., Rota P.A., and Cox N.J. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 13 15 (1995) 1399-1402
5. Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., and Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5 10 (1999) 1157-1163
6. Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., Ye Z., et al. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 13 3 (2007) 426-435
7. Ernst W.A., Kim H.J., Tumpey T.M., Jansen A.D., Tai W., Cramer D.V., et al. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines. Vaccine 24 24 (2006) 5158-5168
8. Jegerlehner A., Schmitz N., Storni T., and Bachmann M.F. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 172 9 (2004) 5598-5605
9. Fan J., Liang X., Horton M.S., Perry H.C., Citron M.P., Heidecker G.J., et al. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 22 23/24 (2004) 2993-3003
10. Liu W., Li H., and Chen Y.H. N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication. FEMS Immunol Med Microbiol 35 2 (2003) 141-146
11. Okuda K., Ihata A., Watabe S., Okada E., Yamakawa T., Hamajima K., et al. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Vaccine 19 27 (2001) 3681-3691
12. De Filette M., Min Jou W., Birkett A., Lyons K., Schultz B., Tonkyro A., et al. Universal influenza A vaccine: optimization of M2-based constructs. Virology 337 1 (2005) 149-161
13. Li H., Ding J., and Chen Y.H. Recombinant protein comprising multi-neutralizing epitopes induced high titer of antibodies against influenza A virus. Immunobiology 207 5 (2003) 305-313
14. Graham M.B., Braciale V.L., and Braciale T.J. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 180 4 (1994) 1273-1282
15. Brown D.M., Roman E., and Swain S.L. CD4 T cell responses to influenza infection. Semin Immunol 16 3 (2004) 171-177
16. Crowe S.R., Miller S.C., Brown D.M., Adams P.S., Dutton R.W., Harmsen A.G., et al. Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine 24 4 (2006) 457-467